The National Cancer Institute (NCI) has announced that it will spend
$144.3 million over the next 5 years to fund cancer-related nanotechnology
research. The institute has formed the new NCI Alliance for Nanotechnology
in Cancer, which will implement the Cancer Nanotechnology Plan. Nanotechnology
incorporates the design and use of devices at the nanometer scale.
Within the first 3 years, the plan calls for acceleration of projects
that hold promise for near-term clinical application. For subsequent years,
the plan will focus on difficult technological and biological problems that
could have the potential to have an impact on cancer detection and treatment.
Additional information about the plan can be found at http://nano.cancer.gov.
Hampton T. Nanotechnology and Cancer. JAMA. 2004;292(16):1946. doi:https://doi.org/10.1001/jama.292.16.1946-c
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: